ArticleJournal of managed care & specialty pharmacy2023

Commercial health plans use of patient subgroup restrictions: An analysis of orphan and US Food and Drug Administration-expedited programs.

Nola B Jenkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.